Jong Soo Woo,Hong-Gi Yi,Moon-Hyuk Chi,Jae-Kuk Ryu,Si-Young Jung,Yong-Il Kim
申请号：
US10599729
公开号：
US08475840B2
申请日:
2005.04.08
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The sustained release formulation for oral administration of an HMG-CoA reductase inhibitor of the present invention can be easily and economically prepared and is capable of maintaining a constant drug level in blood by slowly releasing the HMG-CoA reductase inhibitor at a uniform rate for 24 hrs. Accordingly, the sustained release formulation of the present invention can be effectively used for lowering blood cholesterol and triglyceride levels.
